|
GB1298084A
|
|
Capsules and other self-supporting medicinal packaging means
|
|
GB1272477A
|
|
2-hydroxy-5-amino-benzamide derivatives
|
|
GB1280355A
|
|
Substituted 5-nitro-imidazoles and their preparation
|
|
GB1285361A
|
|
Improvements in or relating to pyrazolidine derivatives
|
|
GB1274199A
|
|
Improvements in or relating to emetine derivatives
|
|
GB1274200A
|
|
Improvements in or relating to adamantane derivatives
|
|
GB1209750A
|
|
Improvements in or relating to 2,2,6,6,-tetramethyl piperidine and 1,2,3,6,-tetrahydro-2,2,6,6-tetramethyl pyridine derivatives
|
|
GB1175823A
|
|
Improvements in or relating to Piperidine Derivatives
|
|
GB1172998A
|
|
Improvements in or relating to Piperidine and Tetrahydropyridine Derivaties
|
|
GB1190770A
|
|
Improvements in or relating to Piperidine Derivatives
|
|
GB1174412A
|
|
Improvements in or relating to Piperazine Derivatives
|
|
GB1165334A
|
|
Improvements in or relating to Thiadiazepine
|
|
GB1143371A
|
|
Improvements in or relating to 2,2,6,6-tetramethyl-piperidine derivatives
|
|
GB1171605A
|
|
Improvements in or relating to N-(beta-Alkoxy-beta-Phenyl-Ethyl)-Pyridinium Derivatives
|
|
GB1141606A
|
|
Improvements in alkyl ethers of substituted phenylaminoethanols
|
|
DE1620256A1
|
|
Process for the preparation of derivatives of 6- [D (-) - alpha- (Amino-phenylacetamido)] - penicillanic acid
|
|
GB1081093A
|
|
Improvements in or relating to 6-[d(-)-alpha-(amino-phenylacetamido)]-penicillanic acid derivatives
|
|
GB1047028A
|
|
Improvements in or relating to 5-acetamido-salicylamide derivatives
|
|
ES256968A1
|
|
Procedure for the manufacture of a new derivative of tetracycline (Machine-translation by Google Translate, not legally binding)
|
|
US3149114A
|
|
New derivative of tetracycline and process for the preparation thereof
|
